A vaccine developed by a Chinese pharmaceutical group could be ready by the end of this year, according to state media.

Liu Jingzhen, chairman of China National Pharmaceutical Group (Sinopharm), said human trials are expected to be completed within the next three months.
Sinopharm’s unit China National Biotec Group had warned that a vaccine might be delayed as a lack of infections in China made it difficult to find people to test it on. However it is now being trialled at a number of overseas sites, including the UAE.

Another vaccine by Chinese firm Sinovac Biotech was tested on people in Brazil.